Blood: Molecular mechanisms of B-ALL hyperxaid cells with filament division and chromosomal defects
-
Last Update: 2020-05-29
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
B-cell acute lymphoblastic leukemia (B-ALL) is the most common childhood cancer, and hyper-hyperphee (HyperD) is the most common subtype of B-ALL in childrenAlthough HyperD is the initial carcinogenic event of B-ALL in children, there is still a lack of characteristics associated with fission disdivision and chromosomal defects associated with HyperD B-ALL (HyperD-ALL)in this study, Oscar et alused samples from 54 primary children b-ALL to characterize potential cellular-molecular mechanisms for fissoprosy/chromosome defects, which are predicted to be early causal factors in HyperD-ALLfound that HyperD-ALL mother cells had low proliferation, showed early filamental prostake delay, which was associated with chromosomal alignment defects on the mid-stage plate, leading to chromosomal separation defects and non-modal nucleiIn the mechanism, biochemical, functional and mass spectrometry analysis showed that the coagulation complex in HyperD-ALL cells was damaged, resulting in reduced chromosomal coagulation, loss of filament hardness, and abnormal positioning of the chromosome passenger complex protein Aurora B kinase (AURKB) and Survivin in early filament divisionin addition, HyperD-ALL cells also exhibit staining monomer coagulation defects and damage to spindle assembly checkpoints (SAcs), which, therefore, in the downstream of coagulant complex defects, due to AURKB defects and damage to SAC activity, resulting in fission-splittingUnder AURKB and/or SAC inhibition, healthy CD34-dry/progenitor cells appear chromosomal structure/coagulation defects and super-dicosmoverall, hyperdipidal B-ALL is associated with defective coagulin complexes, AURKB, and SAcs
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.